Company: IONQ
Filing Date: 2025-10-14
Form Type: 8-K
Source: 0001193125-25-238353
Chunk: 0

Company: IonQ, Inc.
Filing Date: 2025-10-14
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01      Other Events.  

On October 10, 2025, IonQ, Inc. (the “ Company”) entered into an underwriting agreement (the “ Underwriting Agreement”) with J. P. Morgan Securities LLC as the sole underwriter, providing for the offer and sale of (i) 16,500,000 shares (the “ Shares”) of the Company’s common stock, par value $0.0001 per share (“ Common Stock”), (ii) 5,005,400 pre-fundedwarrants (the“ Pre-FundedWarrants”) to purchase an aggregate of 5,005,400 shares of Common Stock and (iii) 43,010,800 warrants (the “ Series B Warrants” and, together with thePre-FundedWarrants, the “ Warrants”) to purchase 43,010,800 shares of Common Stock. Each share of Common Stock was offered with two Series B Warrants to purchase two shares of Common Stock at a combined price to the public of $93.00. Each Pre-Funded Warrant was offered with two Series B Warrants to purchase two shares of Common Stock at a combined price to the public of $93.00 (with a nominal exercise price of $0.0001 per share remaining unpaid as of the issuance date with respect to each Pre-Funded Warrant). The shares of Common Stock, the Series B Warrants and the Pre-Funded Warrants will be issued separately and not as a unit.

The Series B Warrants are being issued pursuant to a Warrant Agreement, dated October 14, 2025 (the “ Series B Warrant Agreement”), between the Company and Continental Stock Transfer & Trust Company, as warrant agent. The Pre-FundedWarrants are being issued pursuant to aPre-FundedWarrant Agreement, dated October 14, 2025 (the“ Pre-FundedWarrant Agreement” and together with the Series B Warrant Agreement, the “ Warrant Agreements”), between the Company and Continental Stock Transfer & Trust Company, as warrant agent.